Expert witness standards in biotechnology litigation

Introduction

Biotechnology litigation involves legal disputes concerning genetic engineering, pharmaceutical products, biological research, medical devices, genetically modified organisms, clinical trials and intellectual property rights. Such disputes frequently require courts to examine complicated scientific and technical evidence that cannot be properly understood through ordinary legal arguments alone.

Expert witnesses play an important role in these proceedings by explaining scientific findings, evaluating experimental methods, interpreting genetic evidence and identifying potential safety violations. Their testimony assists courts in determining whether a biotechnology product is defective, a research procedure is unlawful, a patent claim is scientifically supported or a regulatory requirement has been violated.

Expert witness standards establish the qualifications, independence, methodology and evidentiary reliability required from specialists providing opinions in biotechnology-related disputes.

Meaning and importance of expert witness standards

An expert witness is an individual possessing specialised scientific, technical or professional knowledge who provides an opinion to assist a court in resolving a particular issue.

In biotechnology litigation, experts may include molecular biologists, geneticists, microbiologists, bioinformaticians, pharmaceutical scientists, toxicologists and biomedical engineers.

Their principal responsibilities include:

Explaining complex biological and genetic processes.

Evaluating experimental and clinical research data.

Examining the safety of biotechnology products.

Assessing genetic engineering techniques.

Interpreting DNA sequencing and laboratory findings.

Evaluating pharmaceutical manufacturing defects.

Explaining patent-related scientific questions.

Identifying scientific errors and research misconduct.

Expert testimony is particularly important because biotechnology disputes often involve uncertainty, specialised terminology and rapidly developing scientific methods.

Legal framework in India

1. Bharatiya Sakshya Adhiniyam, 2023

The Bharatiya Sakshya Adhiniyam, 2023 (BSA), provides the principal evidentiary framework governing expert opinions in applicable proceedings.

Section 39 recognises expert opinions as relevant when courts must form opinions on specialised matters, including science and technology.

In biotechnology litigation, this provision may apply to expert opinions concerning genetic sequencing, molecular biology, pharmaceutical composition, biological safety and computational research.

However, expert opinion is not automatically conclusive. Courts must independently evaluate the expert's qualifications, scientific methods and supporting evidence.

2. Code of Civil Procedure, 1908

Civil biotechnology disputes involving patent infringement, defective products, contractual obligations and commercial research agreements are governed by the applicable civil procedural framework.

Order XXVI Rule 10A of the CPC allows courts to issue commissions for scientific investigation where questions arising in a suit require such investigation.

This provision can assist courts in obtaining independent scientific examination in technically complicated biotechnology disputes.

3. Patents Act, 1970

The Patents Act provides the legal framework for biotechnology-related patent disputes.

Section 10 establishes disclosure requirements for patent specifications, while Section 64 provides grounds for revocation of patents.

Expert witnesses may assist courts in understanding whether an invention is novel, involves an inventive step, satisfies disclosure requirements or falls within statutory exclusions.

4. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986, and the Rules of 1989 regulate specified activities involving hazardous microorganisms and genetically engineered organisms.

Scientific experts may provide evidence concerning biosafety procedures, environmental risks, genetic modifications and compliance with regulatory conditions.

Essential standards for biotechnology expert witnesses

1. Academic and professional qualifications

An expert should possess qualifications relevant to the scientific issue involved. Suitable backgrounds may include:

Biotechnology and molecular biology.

Genetics and genomics.

Bioinformatics and computational biology.

Pharmaceutical sciences.

Microbiology and toxicology.

Biomedical engineering.

Environmental biotechnology.

A general scientific qualification may not be sufficient when the dispute involves a highly specialised biotechnology technique.

2. Practical experience

Professional experience helps establish whether an expert understands the scientific procedures and technologies involved.

Relevant experience may include laboratory research, clinical studies, genetic testing, pharmaceutical development, biosafety assessments and biotechnology manufacturing.

3. Scientific reliability

An expert must rely on appropriate scientific methods and verifiable evidence. The expert should explain the testing procedures, research design, analytical tools and limitations of the conclusions.

For example, an expert examining a genetically modified crop should identify the testing methods used to evaluate genetic stability, environmental interaction and potential ecological effects.

4. Independence and impartiality

Experts must provide objective opinions rather than advocate for the party appointing them. Any financial relationship, professional interest or institutional conflict should be disclosed where relevant.

5. Reproducibility and documentation

Scientific conclusions should be supported by properly maintained laboratory records, experimental protocols, raw data and analytical reports.

Where possible, important findings should be independently verified.

Important case laws

1. State of H.P. v. Jai Lal (1999)

The Supreme Court explained that expert opinion becomes relevant when a court must form an opinion on a specialised subject. It emphasised that an expert must possess special knowledge or skill and that the court must independently evaluate the opinion.

This judgment provides an important foundation for determining the competency and evidentiary value of biotechnology experts.

2. Novartis AG v. Union of India (2013)

The Supreme Court examined pharmaceutical patentability under Section 3(d) of the Patents Act, 1970. It emphasised the importance of demonstrating enhanced therapeutic efficacy through appropriate evidence.

The judgment is relevant to biotechnology patent disputes because scientific claims concerning pharmaceutical inventions must be supported by credible technical material.

3. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

The Supreme Court examined patent-related disputes concerning genetically modified cotton seeds and technology licensing. It set aside the Delhi High Court's decision and remanded the matter for further consideration.

The case demonstrates the technical complexity of biotechnology patent litigation and the importance of properly examining scientific and legal issues. It did not finally determine every question concerning the patentability of the technology.

4. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making, particularly where complex technical questions and scientific uncertainty are involved.

Its reasoning is relevant to biotechnology disputes involving biosafety, genetically modified organisms and environmental risks.

5. Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993), United States

The US Supreme Court established important considerations for evaluating scientific expert testimony. These include testability, peer review, potential error rates and general acceptance within the relevant scientific community.

Although not binding in India, the decision provides useful comparative principles for assessing the reliability of scientific evidence in biotechnology litigation.

These cases address general expert-evidence principles, biotechnology patent disputes and scientific assessment. They do not establish a single specialised statutory qualification standard for all biotechnology expert witnesses.

Challenges in biotechnology litigation

Biotechnology litigation presents several difficulties because scientific knowledge develops rapidly and technical evidence may be highly specialised.

Major challenges include:

Different scientific interpretations of experimental results.

Difficulty accessing proprietary research data.

Conflicting opinions between experts.

Uncertainty concerning long-term biological effects.

Incomplete laboratory documentation.

Potential conflicts of interest.

Difficulty explaining complex scientific concepts to judges.

Questions concerning the reliability of AI-based scientific analysis.

Another significant issue is distinguishing between scientifically established conclusions and preliminary research findings. Experts must clearly identify the limitations of available evidence.

Safeguards for reliable expert testimony

An effective expert-evidence framework should require transparent scientific methods and independent evaluation.

Important safeguards include:

Verification of academic and professional credentials.

Disclosure of relevant financial and institutional interests.

Examination of original experimental records.

Independent validation of significant scientific findings.

Use of recognised laboratory and testing standards.

Disclosure of software, analytical methods and statistical limitations.

Opportunity for cross-examination.

Clear separation of scientific opinion from legal conclusions.

Courts should also ensure that experts explain technical matters in understandable language without exaggerating the certainty of their findings.

Conclusion

Expert witness standards in biotechnology litigation are essential for ensuring that complex scientific disputes are decided through reliable and impartial evidence. Section 39 of the Bharatiya Sakshya Adhiniyam, 2023, provides the evidentiary foundation for expert opinions, while the Patents Act, 1970, and environmental regulations establish relevant substantive legal requirements. Judicial decisions such as State of H.P. v. Jai Lal, Novartis AG v. Union of India and A.P. Pollution Control Board v. Prof. M.V. Nayudu demonstrate the importance of scientific expertise and careful judicial evaluation. A strong framework must combine professional competence, methodological reliability, independence and transparency to ensure fair outcomes in biotechnology litigation.